HKB's Mouse Autoimmune Hepatitis Models provide pharmaceutical researchers with robust platforms for investigating this serious autoimmune liver condition. Our validated rodent models utilize ConA injection, alpha-GalCer treatment, or genetic approaches to replicate key features of AIH including hepatocyte destruction, interface hepatitis, and autoimmune activation.
HkeyBio is a China-based, globally-focused preclinical CRO dedicated exclusively to autoimmune and allergic diseases, with a unified service network across Asia, the Americas, Europe and Australia.